Key Highlights
- UnitedHealth delivered Q2 adjusted EPS of $6.38, significantly beating the $4.91 consensus forecast
- Quarterly revenue totaled $112 billion, surpassing Wall Street’s $110.8 billion projection
- Company increased full-year adjusted EPS outlook to $19.50–$20.00 per share
- Medical-cost ratio dropped to 86.7%, compared to 89.4% in the prior-year period
- Competitor insurers including Humana, Centene, and Molina climbed higher in premarket action
Shares of UnitedHealth Group surged approximately 7% during premarket hours Thursday following the healthcare giant’s announcement of second-quarter financial results that exceeded expectations and an improved full-year forecast.
UnitedHealth Group Incorporated, UNH
The company reported adjusted earnings of $6.38 per share, significantly outpacing analyst predictions of roughly $4.85–$4.91. This represents a substantial beat of more than $1.50 per share—a meaningful outperformance by any measure.
Quarterly revenue totaled $112 billion, topping the Street’s expectation of $110.8 billion. This marks an increase from $111.6 billion reported during the comparable period last year.
[[EMBED_0]]The medical-cost ratio—which measures the percentage of premium revenue spent on medical claims—improved to 86.7%. This represents a decline from 89.4% posted in Q2 2025 and beats the 88.4% analysts were anticipating. Company leadership attributed the improvement to enhanced benefit designs, more disciplined pricing strategies, and tighter medical expense controls.
Operating earnings climbed to $8.0 billion, a notable jump from $5.2 billion during the second quarter of 2025.
Outlook Receives Significant Boost
Building on the robust quarterly performance, UnitedHealth elevated its full-year 2026 adjusted earnings forecast to a range of $19.50 to $20.00 per share. The $19.75 midpoint substantially exceeds the analyst consensus of $18.48–$18.49. The company’s previous guidance had established a floor of $18.25.
Management also increased its full-year cash flow projection to roughly $24 billion, a significant upgrade from the previous target of over $18 billion.
Operating cash flows totaled $11.1 billion during the quarter, representing 1.9 times net income. Through mid-July, UnitedHealth has repurchased $4 billion worth of its own shares and anticipates buying back at least $5 billion throughout the full year.
Business Unit Performance
UnitedHealthcare provided coverage to 48.5 million individuals during the quarter, posting revenues of $86 billion alongside earnings of $3.9 billion. The division’s operating margin widened to 4.6%, up from 2.4% in the year-ago quarter.
Optum, the company’s healthcare services division, produced revenues of $65.7 billion and earnings of $4.0 billion, achieving 160 basis points of year-over-year margin expansion.
Chief Executive Stephen Hemsley noted the results demonstrate “continuing progress in our work to simplify how we operate, improve both affordability and the health care experience for patients and care providers.”
The impressive results created a ripple effect across the healthcare insurance sector. Humana shares climbed 4.8% in premarket trading, Centene advanced 4.6%, and Molina Healthcare gained 2.9%.
UnitedHealth’s approximately 7% premarket rally pushed the stock toward $448.50, up from its previous closing price of around $418.52.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
